Jed Latkin
CIK 1554593 · CEO, COO & CFO · last filed 2024-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
15
Lifetime Open-Market Net
$34.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRPH | Director | — | $0.11 | — | $0 | 1 | 2024-03-19 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | CEO, COO & CFO | 118,597 | $0.00 | $12 | $34.8K | 14 | 2021-02-17 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-05-31 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Buy (P) | +7,600 | $3.3K | EDGAR |
| 2017-05-23 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Buy (P) | +25,359 | $11.4K | EDGAR |
| 2017-05-19 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +17,200 | $8.0K | EDGAR |
| 2017-05-05 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-01 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.